Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
European Journal of Neurology|May 28, 2026
Bevacizumab for Radiation-Induced (Radiculo)plexopathyAlberto Picca, Timothée Lenglet, Christophe Vandendries, et al.The Oncologist|November 24, 2025
Advances in the management of patients with IDH-mutant gliomaJessica Rossi, Alberto Picca, Orazio Santo Santonocito, et al.British Journal of Clinical Pharmacology|August 26, 2022
Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance studyAlberto Picca, Cristina Birzu, Giulia Berzero, et al.Cancers|March 10, 2022
Innovating Strategies and Tailored Approaches in Neuro-OncologyAlberto Picca, David Guyon, Orazio Santo Santonocito, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 21, 2020
Adult brainstem glioma: a multicentre retrospective analysis of 47 Italian patientsAndrea Rigamonti, Giorgia Simonetti, Antonio Silvani, et al.Neurology|May 6, 2018
<i>FGFR1</i> actionable mutations, molecular specificities, and outcome of adult midline gliomasAlberto Picca, Giulia Berzero, Franck Bielle, et al.European Journal of Cancer (Oxford, England : 1990)|March 27, 2024
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomasAlberto Picca, Mehdi Touat, Lisa Belin, et al.Nature Cancer|February 2, 2023
Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapySimona Migliozzi, Young Taek Oh, Mohammad Hasanain, et al.Nature Communications|November 14, 2024
Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomesAndré Bortolini Silveira, Alexandre Houy, Olivier Ganier, et al.Brain Pathology (Zurich, Switzerland)|October 5, 2017
Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular featuresFranck Bielle, Anna-Luisa Di Stefano, David Meyronet, et al.Pageof 4